North America Fill Finish Manufacturing Market
The North America Fill Finish Manufacturing Market size was valued at US$ 3,439.58 Mn in 2022 and is projected to reach US$ 6,505.56 Mn by 2030, growing at a CAGR of 8.3% during 2022 - 2030.
Report Coverage
- Product: Consumables, Instruments
- Modality: Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Therapies and Biological Therapies, Gene Therapies
- End User: Contract Manufacturing Organizations, Biopharmaceutical Companies
US$ 3,439.58 Mn
Market size in 2022
US$ 6,505.56 Mn
Market Size by 2030
8.3%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Fill Finish Manufacturing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Fill Finish Manufacturing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Fill Finish Manufacturing Market Regional Analysis
6.2 North America Fill Finish Manufacturing Market Revenue 2020-2030 (US$ Million)
6.3 North America Fill Finish Manufacturing Market Forecast Analysis
7. North America Fill Finish Manufacturing Market Analysis – by Product
7.1 Consumables
- 7.1.1 Overview
- 7.1.2 Consumables: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Fill Finish Manufacturing Market Analysis – by Modality
8.1 Recombinant Proteins
- 8.1.1 Overview
- 8.1.2 Recombinant Proteins: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Monoclonal Antibodies
- 8.2.1 Overview
- 8.2.2 Monoclonal Antibodies: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Vaccines
- 8.3.1 Overview
- 8.3.2 Vaccines: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Cell Therapies and Biological Therapies
- 8.4.1 Overview
- 8.4.2 Cell Therapies and Biological Therapies: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Gene Therapies
- 8.5.1 Overview
- 8.5.2 Gene Therapies: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Fill Finish Manufacturing Market Analysis – by End User
9.1 Contract Manufacturing Organizations
- 9.1.1 Overview
- 9.1.2 Contract Manufacturing Organizations: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Biopharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Biopharmaceutical Companies: North America Fill Finish Manufacturing Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Fill Finish Manufacturing Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Fill Finish Manufacturing Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 North America Fill Finish Manufacturing Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Fill Finish Manufacturing Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America Fill Finish Manufacturing Market Breakdown, by Product
- 10.2.1.1.2 US: North America Fill Finish Manufacturing Market Breakdown, by Modality
- 10.2.1.1.3 US: North America Fill Finish Manufacturing Market Breakdown, by End User
- 10.2.1.2 Canada: North America Fill Finish Manufacturing Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America Fill Finish Manufacturing Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Fill Finish Manufacturing Market Breakdown, by Modality
- 10.2.1.2.3 Canada: North America Fill Finish Manufacturing Market Breakdown, by End User
- 10.2.1.3 Mexico : North America Fill Finish Manufacturing Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America Fill Finish Manufacturing Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Fill Finish Manufacturing Market Breakdown, by Modality
- 10.2.1.3.3 Mexico : North America Fill Finish Manufacturing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Becton Dickinson and Co
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Gerresheimer AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Groninger and Co GmbH
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 IMA Industria Macchine Automatiche SpA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Maquinaria Industrial Dara SL
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Nipro Medical Europe NV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 NNE AS
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Optima Packaging Group Gmbh
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Schott AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 SGD SA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Stevanato Group SpA
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Syntegon Technology GmbH
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 West Pharmaceutical Services Inc
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
